Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype

Molecular Carcinogenesis

Volumn 20, Issue 1, 1997, Pages 115-124

  Kim, Tae Won ^a   Porter, Karen L ^a   Foley, Julie F ^b   Maronpot, Robert R ^b   Smart, Robert C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

BrdU; Carcinogenesis; Keratinocytes; Proliferating cell nuclear antigen; Skin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BROXURIDINE; CYCLINE; MIREX; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR PROMOTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BROMODEOXYURIDINE; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELLS, CULTURED; COCARCINOGENESIS; FEMALE; GENES, RAS; GENOTYPE; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MICE; MICE, INBRED BALB C; MIREX; MUTATION; NITROSOUREA COMPOUNDS; PAPILLOMA; S PHASE; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA;

EID: 0030733818     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199709)20:1<115::AID-MC13>3.0.CO;2-4     Document Type: Conference Paper

References (25)

1. Moser GJ, Meyer SA, Smart RC. The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin. Cancer Res 52:631-636, 1992.
2. Moser GJ, Robinette CL, Smart RC. Characterization of skin tumor promotion by mirex: Structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation. Carcinogenesis 14:1155-1160, 1993.
3. Meyer SA, Kim TW, Moser GJ, Monteiro-Riviere NA, Smart RC. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion. Carcinogenesis 15:47-52, 1994.
4. Kim TW, Smart RC. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism. Carcinogenesis 16:2199-2204, 1995.
5. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 326:515-517, 1987.
6. Fairman MP. DNA polymerase δ/PCNA: Actions and interactions. J Cell Sci 95:1-4, 1990.
7. Prehlich G, Tan CK, Kostura M, et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein. Nature 326:517-520, 1987.
8. Weissman BE, Aaronson SA. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines. Cell 32:599-606, 1983.
9. Foley J, Ton T, Maronpot R, Butterworth B, Goldsworthy TL. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect 101:199-205, 1993.
10. Bianchi AB, Fisher SM, Robles Al, Rinchik EM, Conti CJ. Overexpression of cyclin D1 in mouse skin Carcinogenesis. Oncogene 8:1127-1133, 1993.
11. Owens DM, Zainal TA, Jetten AM, Smart RC. Localization and expression of cornifin-α/SPRR1 in mouse epidermis, anagen hair follicles, and skin neoplasms. J Invest Dermatol 106:647-654, 1996.
12. Gimenez-Conti IB, Aldaz CM, Bianchi AB, Roop DR, Slaga TJ, Conti CJ. Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis 11:1995-1999, 1990.
13. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis 11:2245-2251, 1990.
14. Yuspa SH, Ben T, Hennings H, Lichti U. Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun 97:700-708, 1980.
15. Verma AK, Boutwell RK. Effects and duration of treatment with the tumor promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin. Carcinogenesis 1:271-276, 1980.
16. Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6:1607-1610, 1985.
17. Yuspa SH. The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis - Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 54:1178-1189, 1994.
18. Furstenberger G, Kopp-Schneider A. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis 16:61-69, 1995.
19. Owens DM, Spalding JW, Tennant RW, Smart RC. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Cancer Res 55:3171-3178, 1995.
20. Cotsarelis G, Sun T-T, Lavker RM. Label-retaining cells reside in the bulge area of the pilosebaceous unit: Implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 61:1329-1337, 1990
21. Morris RJ, Fischer SM, Slaga TJ. Evidence that a slowly cycling population of adult murine epidermal cells retains carcinogen. Cancer Res 46:3061-3066, 1986.
22. Miller SJ, Wei Z-G, Wilson C, Dzubow L, Sun T-T, Lavker RM. Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: Possible involvement of the hair follicle stem cells. J Invest Dermatol 101:591-594, 1993.
23. Ha oncogene in mouse carcinogenesis. Carcinogenesis 12:1119-1124, 1991.
24. Oh H-S, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 93:12525-12530, 1996.
25. Robinette CL, Smart RC. Estradiol-17β enhances the tumor promoting effects of mirex. Fed Proc 10:1047, 1996.